Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-14

Clinical Trial Update: A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 trial completed to assess the contact sensitization potential of tazarotene foam on the skin in healthy volunteers. The study is associated with acne …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tazarotene foam (tazarotene)

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED